Neuroscience
Amygdala
10%
Antiviral Drug
21%
Antivirals
65%
Brainstem
10%
Cognitive Behavioral Therapy
65%
Cognitive Disorders
27%
Dementia Praecox
81%
Frontal Lobe
10%
Gyri
10%
Herpesviridae
10%
Hippocampus
32%
Nucleus Accumbens
10%
Occipital Lobe
10%
Parahippocampal Gyrus
10%
Paranoia
65%
Parietal Lobe
10%
Placebo
10%
Positron Emission Tomography
65%
Positron Emission Tomography
10%
Psychological Treatment
11%
Psychosis
100%
Randomized Controlled Trial
5%
Social Isolation
5%
Temporal Lobe
10%
Thalamus
10%
Translocator Protein
10%
Valaciclovir
65%
Keyphrases
Behavioral Experiment
9%
Clinical Impression
9%
Cognitive Behavioral Therapy
65%
Cognitive Behavioral Therapy for Psychosis
65%
Cognitive Cluster
10%
Cognitive Subgroups
65%
Cost-effectiveness
9%
Daily Life
18%
DSM-5 Diagnosis
9%
Ecological Momentary Assessment
9%
Exposure Experiment
9%
Hippocampal Inflammation
10%
Hospital Admission
9%
Multicenter Randomized Controlled Trial
9%
Paranoid Ideation
37%
Paranoid Thinking
65%
Patient's Will
9%
Psychological Treatment
18%
Psychotic Disorders
37%
Random Moments
9%
Relative Cost
9%
Semi-random
9%
Social Anxiety
9%
Social Functioning
9%
Social Isolation
9%
Social Situation
18%
Superiority Trial
65%
Therapist
9%
Virtual Reality
65%
Waiting List
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
65%
Binding Potential
9%
Carrier Protein
9%
Cognitive Defect
9%
Herpes Virus Infection
9%
Inflammation
9%
N Sec Butyl 1 (2 Chlorophenyl) N Methyl 3 Isoquinolinecarboxamide C 11
9%
Nervous System Inflammation
65%
Placebo
9%
Protein Ligand
9%
Psychosis
9%
Symptom
37%
Valaciclovir
65%
Volume of Distribution
9%
